1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GH RESEARCH PLC
GH Research PLC
XNAS: GHRS
18.85 -1.17 (-5.84%)
425.5K
XNAS Volume

XNAS 13 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for GH Research PLC

The latest disclosure was made by Dr. Duncan Moore, PhD in GH Research PLC where a trade of 2,202 Share Options (Right to Buy) done was reported to US exchanges on Aug. 11, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dr. Duncan Moore, PhD Director 11 Aug 2026 2,202 2,202 - - Share Options (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures